{
    "2020-07-13": [
        [
            {
                "time": "2023-10-01",
                "original_text": "Roche Forecasted to Be Top Drug Seller in 2026",
                "features": {
                    "keywords": [
                        "Roche",
                        "Forecasted",
                        "Top Drug Seller",
                        "2026"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2023-10-01",
                "original_text": "Did Hedge Funds Make The Right Call On Novartis AG (NVS)?",
                "features": {
                    "keywords": [
                        "Hedge Funds",
                        "Right Call",
                        "Novartis AG",
                        "NVS"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}